As part of only 10 finalists, Alpha Tau was chosen to participate at the Startup Competition for the upcoming Biomed Conference in Israel, May 23rd, 2017. In addition, Prof. Keisari was invited to orally present the highly potent and conformal Alpha DaRT Treatment for solid cancer tumors. Attending with both local and global major players from the health industry is a great encouragement and opportunity to outline the benefits of the Alpha DaRT Treatment and expand ongoing clinical trials.
